查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2018477

兒童診斷影像市場：按影像方式、年齡層、技術、最終用戶和應用分類的全球市場預測，2026-2032年

Pediatric Imaging Market by Modality, Age Group, Technology, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，兒童診斷影像市場價值將達到 143 億美元，到 2026 年將成長至 156.7 億美元，到 2032 年將達到 297.8 億美元，複合年成長率為 11.04%。

主要市場統計數據
基準年 2025 143億美元
預計年份：2026年 156.7億美元
預測年份 2032 297.8億美元
複合年成長率 (%) 11.04%

了解現代兒童影像技術的發展趨勢，這些趨勢透過整合安全性、準確性和操作效率來重塑臨床決策。

兒童影像領域正經歷技術快速發展與日益成長的臨床需求交織的挑戰，需要在診斷準確性、安全性和工作流程效率之間取得平衡。近年來，臨床、研究和商業領域的相關人員越來越關注能夠減少輻射暴露、提高微觀解剖結構影像品質並縮短掃描時間的成像方式和方案，以滿足兒童的臨床需求。因此，目前的投資討論重點在於平衡資本投入與長期臨床價值，整合新一代硬體和人工智慧驅動的軟體功能，並加強針對技術人員和放射科醫師的兒童專項培訓體系。

技術突破、臨床流程的重新設計以及報銷環境的變化如何共同改變兒童影像診斷的提供方式。

兒童影像領域正經歷一場變革，這場變革由三個緊密相關的因素驅動：技術創新、臨床流程最佳化以及支付方和監管機構不斷變化的期望。檢測器技術、平行成像和迭代重建演算法的進步顯著提高了低劑量下的影像清晰度，使臨床醫生能夠更早、更準確地做出診斷，同時最大限度地降低長期輻射風險。同時，利用機器學習和人工智慧的後處理工具能夠實現自動異常檢測、提高影像品質和最佳化工作流程，從而縮短診斷時間，減輕專科醫生的負擔，使他們能夠專注於更高價值的臨床工作。

分析 2025 年美國關稅措施對兒童診斷影像的籌資策略、供應鏈和臨床應用的整體影響。

2025年宣布的關稅調整的累積影響，為兒童影像設備的採購、製造和臨床部署管道帶來了新的複雜性。關稅上調推高了某些進口零件和整機的到貨成本，迫使製造商重新評估籌資策略，並加快供應鏈本地化進程。因此，由於買家要求透過合約保障價格波動，大型資本設備的採購週期正在延長。同時，供應商正在探索成本導向設計、零件標準化和生產多元化等策略，以在維持性能指標和兒童功能的同時，維持獲利能力。

從高解析度分割的觀點揭示了模態、人口統計和環境因素如何決定兒童影像的優先事項和投資重點。

為了深入了解兒童影像的表現和應用情況，最有效的方法是檢視影像模式選擇、人口統計特徵、技術類型、臨床環境和應用領域如何相互作用，進而影響需求和臨床價值。市場已對電腦斷層檢驗(CT)、磁振造影(MRI)、核子醫學成像（包括正電子發射斷層掃描 (PET) 和單光子發射電腦斷層掃描 (SPECT)）、超音波和 X光等主要影像模式進行了調查，每種模式在速度、解析度和輻射暴露方面都存在獨特的權衡。年齡因素也需要考慮，包括青少年、兒童、嬰兒和新生兒，這些人口統計群體會影響方案設計、儀器人體工學和人員能力要求。此外，影像平台的技術基礎也各不相同，例如電腦放射成像、數位放射線攝影和膠片放射成像，這些都會影響影像工作流程、存檔以及與電子健康記錄的整合。

影響全球兒童影像市場採用路徑、監管參與和能力發展優先事項的區域趨勢和能力差異。

區域趨勢對兒童影像技術的應用模式、監管預期和基礎設施建設進展有顯著影響。在美洲，兒科影像系統展現多樣化的能力，從大都會圈的大規模三級兒童醫療中心到郊區和農村地區的社區醫院和專科診所，不一而足。在該地區，報銷機制和資本規劃週期往往會影響投資時機和技術選擇。相較之下，歐洲、中東和非洲地區的管理體制和公私合營醫療模式各不相同，既存在協調統一的機會，也存在採購管道分散的問題。兒童影像領域的卓越中心通常發揮區域樞紐的作用，負責推廣診療方案和培訓資源。

這代表了企業之間既競爭又合作的方式，加速了兒童醫療保健領域的創新，同時重組了採購模式和服務交付提案。

兒童影像領域的競爭動態呈現出大規模全球系統整合商與專注於兒童特定工作流程、劑量管理和軟體驅動診斷的敏捷型專業創新者並存的態勢。領先的製造商持續投資於檢測器靈敏度、重建演算法和整合人工智慧工具集，以提高兒童影像品質並簡化操作人員的工作。同時，中小型科技公司正在開發專用模組、造影劑和兒童專用配件，以滿足嬰幼兒獨特的人體工學和安全需求。醫療設備製造商、軟體供應商和大學附屬醫院之間的策略夥伴關係正在不斷拓展，從而能夠共同開發檢驗的兒童方案，並加速推進臨床試驗，以驗證產品在真實環境中的表現。

醫療保健領導者可透過模組化投資、強化流程和建立彈性夥伴關係，確保兒童影像計畫的未來發展，可採取切實可行的策略

行業領導者必須採取果斷且基於實證的行動，在應對經濟和監管方面的挑戰的同時，保持卓越的臨床水平。首先，各機構應優先考慮模組化升級策略，以便在無需徹底改造系統的情況下逐步提升影像功能。這有助於在保持資金柔軟性的同時，逐步提高性能。其次，相關人員需要將兒童專用診療方案和人員認證項目制度化，以確保影像品質的一致性，並減少不同機構間影像解讀的差異。第三，領導者應與供應商建立合作關係，包括長期服務保障、培訓承諾以及降低關稅上漲風險的夥伴關係。

為了確保對兒童影像診斷有可靠的見解，我們採用了穩健的混合方法研究方法，該方法整合了主要臨床訪談、次要技術分析和監管審查。

這些研究結果是基於一項多方面研究，該研究結合了對臨床負責人、醫院採購負責人和設備工程師的訪談（以一級資訊來源），以及對監管指南和同行評審的臨床文獻的系統性回顧。定性訪談提供了有關營運挑戰、採購因素以及技術應用在兒童醫療機構中的實際影響的背景資訊。對製造商技術規格和臨床檢驗研究的二次分析有助於評估各種設備的功能和安全性。

整合技術採納策略和營運選擇轉變的關鍵見解，這將決定兒童影像診斷的未來成功。

兒童影像學正處於關鍵的轉折點，技術進步正在切實提高診斷的準確性、安全性和工作流程效率，但其應用需要精心協調臨床目標、籌資策略和人力資源能力。先進的影像技術、人工智慧輔助工具和改進的臨床方案相結合，降低了兒童各專科早期準確診斷的門檻，但其成功取決於精心整合，優先考慮兒童人體工學、放射科管理和臨床醫生繼續教育。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章兒童診斷影像市場：依影像方式分類

  • 電腦斷層掃描
  • 磁振造影
  • 核子醫學掃描術診斷
    • 正子斷層掃描
    • 單光子發射電腦斷層掃描
  • 超音波
  • X光

第9章兒童診斷影像市場：依年齡層別分類

  • 青春期
  • 兒童
  • 嬰兒
  • 新生

第10章兒童診斷影像市場：依技術分類

  • 電腦放射成像
  • 數位放射線攝影
  • 電影螢幕法

第11章兒童診斷影像市場：依最終用戶分類

  • 診所及門診手術中心
  • 診斷中心
  • 醫院
  • 研究機構

第12章兒童診斷影像市場：依應用領域分類

  • 循環系統
  • 普通診斷影像
  • 神經病學
  • 腫瘤學
  • 整形外科

第13章兒童診斷影像市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章兒童診斷影像市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章兒童診斷影像市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國兒童診斷影像市場

第17章：中國兒童診斷影像市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Agfa-Gevaert Group
  • Analogic Corporation
  • Aspect Imaging Ltd
  • BK Medical UK Ltd.
  • Canon Inc.
  • Carestream Health Inc.
  • Esaote SpA
  • FUJIFILM Holdings Corporation
  • GE HealthCare Technologies Inc.
  • Hitachi Ltd.
  • Hologic Inc.
  • Hyperfine
  • Konica Minolta Inc.
  • Koninklijke Philips NV
  • LMT Medical Systems GmbH
  • Mindray Medical International Limited
  • Neoscan Solutions GmbH
  • NORAS MRI products GmbH
  • Samsung Electronics Co., Ltd.
  • Shanghai United Imaging Healthcare Co., Ltd.
  • Shenzhen Anke High-tech Co. Ltd
  • Shenzhen SONTU Medical Imaging Equipment Co., Ltd.
  • Shimadzu Corporation
  • Siemens Healthcare GmbH
  • Time Medical Holding
Product Code: MRR-A339DAEF9F2F

The Pediatric Imaging Market was valued at USD 14.30 billion in 2025 and is projected to grow to USD 15.67 billion in 2026, with a CAGR of 11.04%, reaching USD 29.78 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 14.30 billion
Estimated Year [2026] USD 15.67 billion
Forecast Year [2032] USD 29.78 billion
CAGR (%) 11.04%

Understanding the modern pediatric imaging landscape where safety, precision, and operational efficiency converge to reshape clinical decision-making

Pediatric imaging stands at the intersection of rapid technological advancement and heightened clinical sensitivity, where diagnostic precision must align with safety and workflow efficiency. Over recent years, stakeholders across clinical, research, and commercial domains have intensified focus on modalities and protocols that reduce radiation exposure, improve image quality for small anatomies, and shorten acquisition times to accommodate children's clinical needs. Consequently, investment debates now center on balancing capital intensity with long-term clinical value, integrating next-generation hardware with AI-driven software enhancements, and strengthening pathways for pediatric-specific training among technologists and radiologists.

In this environment, vendors and providers are navigating complex regulatory expectations, reimbursement dynamics, and the operational realities of pediatric care. Transitional technologies such as ultrafast MRI sequences and low-dose CT protocols are reshaping standard practice, while adoption of specialized nuclear imaging tracers and advanced ultrasound capabilities is increasing in tertiary centers. As a result, decision-makers must consider not only device performance but also installation footprints, maintenance regimes, and cross-disciplinary collaboration to ensure programs deliver measurable improvements in clinical outcomes and patient experience.

How technological breakthroughs, clinical pathway redesign, and shifting reimbursement dynamics are jointly transforming pediatric imaging delivery

The pediatric imaging landscape is undergoing transformative shifts driven by three interlocking forces: technological innovation, clinical pathway optimization, and evolving payer and regulatory expectations. Advances in detector technologies, parallel imaging, and iterative reconstruction algorithms have materially improved image clarity at lower doses, enabling clinicians to make earlier and more accurate diagnoses while minimizing long-term radiation risks. Meanwhile, machine learning and AI-based post-processing tools are enabling automated anomaly detection, image enhancement, and workflow prioritization, which together reduce time-to-diagnosis and free up specialist capacity for higher-value clinical tasks.

Concurrently, clinical pathways are being redesigned to favor multidisciplinary models that integrate imaging earlier in diagnostic and treatment planning workflows, supported by tele-radiology networks that extend pediatric expertise beyond tertiary centers. Regulatory emphasis on pediatric-specific labeling and safety assessments has prompted vendors to optimize user interfaces and training materials for pediatric use cases. Moreover, value-based reimbursement experiments and quality metrics tied to patient-centered outcomes are incentivizing providers to demonstrate tangible clinical benefit from imaging investments. These convergent shifts are prompting hospital systems and imaging providers to reassess procurement strategies, prioritize modular upgradeability, and forge partnerships that accelerate time-to-value.

Analyzing the aggregated consequences of United States tariff measures in 2025 on procurement strategies supply chains and clinical deployment for pediatric imaging

The cumulative effects of tariff adjustments announced in 2025 have introduced new complexities across procurement, manufacturing, and clinical deployment channels for pediatric imaging equipment. Tariff increases have raised landed costs for certain imported components and finished systems, prompting manufacturers to reassess sourcing strategies and to accelerate regionalization of supply chains. As a result, procurement cycles for large capital equipment have lengthened while buyers seek contractual protections against price volatility. In parallel, vendors are exploring design-for-cost initiatives, component standardization, and production diversification to preserve margin while maintaining performance specifications and pediatric-focused features.

Clinically, hospitals and imaging centers face trade-offs between delayed upgrades and the need to maintain compliance with pediatric safety standards. Some institutions have postponed elective capital projects, prioritizing essential replacements and modular upgrades that deliver specific clinical benefits such as dose reduction or faster throughput. Transitional arrangements include extended service contracts to maintain uptime and negotiated remanufactured or refurbished options that meet pediatric safety criteria. From a policy perspective, stakeholders are engaging with trade and health authorities to clarify classification and exemptions for pediatric-critical devices. In the near term, decision-makers must integrate total cost of ownership modeling and contingency planning into procurement evaluations to account for tariff-driven variability and to protect clinical continuity for pediatric populations.

High-resolution segmentation-driven perspectives that reveal how modality demographic and setting variables determine pediatric imaging priorities and investment focus

Insight into pediatric imaging performance and adoption is best understood by examining how modality selection, demographic characteristics, technology types, clinical settings, and application areas interact to shape demand and clinical value. The market is examined across core modalities including Computed Tomography, Magnetic Resonance Imaging, Nuclear Imaging-which itself encompasses Positron Emission Tomography and Single Photon Emission Computed Tomography-Ultrasound, and X-Ray, with each modality presenting distinct trade-offs in speed, resolution, and radiation exposure. Age-based considerations span adolescent, child, infant, and newborn cohorts, and these demographic windows drive protocol design, device ergonomics, and staff competency requirements. Furthermore, imaging platforms vary by technology backbone across Computed Radiography, Digital Radiography, and Film-Screen Radiography, affecting image workflow, archiving, and integration with electronic health records.

The environment in which imaging is delivered, including clinics and ambulatory surgical centers, diagnostic centers, hospitals, and research institutes, dictates different procurement and utilization patterns, workforce skill mixes, and expectations for throughput and uptime. Application domains such as cardiology, general imaging, neurology, oncology, and orthopedics impose distinct image quality and contrast agent requirements, which in turn influence modality preference and investment prioritization. By synthesizing these segmentation lenses, decision-makers can identify where technology upgrades will yield the highest clinical return, where training investments are most urgent, and how to configure service-level agreements that reflect pediatric-specific usage profiles.

Regional dynamics and capability variations that shape pediatric imaging adoption pathways regulatory interactions and capacity development priorities across global markets

Regional dynamics materially influence adoption patterns, regulatory expectations, and infrastructure readiness for pediatric imaging. Across the Americas, systems exhibit diverse capacity ranging from large tertiary pediatric centers in metropolitan areas to community hospitals and specialist clinics in suburban and rural settings; reimbursement frameworks and capital planning cycles in this region often shape investment timing and technology choice. By contrast, Europe, Middle East & Africa present a mosaic of regulatory regimes and public-private care models where harmonization opportunities coexist with fragmented procurement routes; centers of excellence in pediatric imaging often act as regional hubs, disseminating protocols and training resources.

In the Asia-Pacific region, rapid hospital expansion coupled with growing investments in advanced diagnostics is driving accelerated adoption of newer modalities, while disparities in workforce specialization persist across markets. Supply chain footprints and local manufacturing capabilities differ by region, influencing lead times for equipment and availability of spare parts. Cross-border collaborations and tele-radiology networks are increasingly important mechanisms for disseminating pediatric expertise across regions, and region-specific policy initiatives aimed at improving child health are prompting targeted investments in imaging capacity and training programs.

Competitive and collaborative company behaviors that are accelerating pediatric-focused innovation while reshaping procurement models and service delivery propositions

Competitive dynamics in pediatric imaging reflect a mix of large global systems integrators and agile niche innovators focused on pediatric-specific workflows, dose management, and software-enabled diagnostics. Major manufacturers continue to invest in detector sensitivity, reconstruction algorithms, and integrated AI toolsets that enhance pediatric imaging quality while simplifying operator tasks. At the same time, smaller technology firms are advancing specialized modules, contrast agents, and pediatric-centric accessories that address unique ergonomic and safety requirements for infants and young children. Strategic partnerships between device manufacturers, software vendors, and academic medical centers are proliferating, enabling co-development of validated pediatric protocols and facilitating clinical trials that demonstrate real-world performance.

Service providers and third-party maintenance organizations are also evolving their offerings to include predictive maintenance, remote diagnostics, and outcome-oriented service packages tailored to pediatric caseloads. Capital equipment vendors are experimenting with innovative financing arrangements and subscription models that lower upfront barriers for smaller hospitals and diagnostic centers. For purchasers, this competitive landscape translates into a wider menu of options but also necessitates rigorous vendor evaluation criteria that prioritize pediatric safety features, upgrade paths, data interoperability, and demonstrated clinical support for pediatric workflows.

Actionable strategies for healthcare leaders to future-proof pediatric imaging programs through modular investments enhanced protocols and resilient partnerships

Industry leaders must take decisive, evidence-based actions to sustain clinical excellence while navigating economic and regulatory headwinds. First, organizations should prioritize modular upgrade strategies that allow phased enhancement of imaging capabilities without committing to full system replacement, thereby preserving capital flexibility and enabling incremental performance gains. Second, stakeholders need to institutionalize pediatric-specific protocols and staff credentialing programs to ensure consistent image quality and to reduce variability in interpretation across facilities. Third, leaders should cultivate supplier partnerships that include long-term service guarantees, training commitments, and clauses that mitigate exposure to tariff-driven cost escalations.

Furthermore, healthcare executives should invest in data governance frameworks that enable the secure deployment of AI tools and that support quality assurance programs linked to clinical outcomes. Collaborative initiatives with regional centers of excellence can help disseminate best practices and accelerate workforce capacity building. Finally, decision-makers should adopt robust scenario planning that incorporates procurement contingencies, spare part inventories, and alternative financing structures to protect clinical continuity and to capitalize on strategic opportunities as the pediatric imaging environment evolves.

Robust mixed-method research approach integrating primary clinical interviews secondary technical analyses and regulatory review to ensure reliable pediatric imaging insights

The research underpinning these insights drew on a multi-method approach combining primary-source interviews with clinical leaders, hospital procurement officers, and device engineers, along with systematic review of regulatory guidance and peer-reviewed clinical literature. Qualitative interviews provided context on operational challenges, procurement drivers, and the practical implications of technology adoption in pediatric settings. Secondary analysis of manufacturer technical specifications and clinical validation studies informed the assessment of modality capabilities and safety features.

Data synthesis emphasized triangulation across sources to ensure reliability, and special attention was paid to differentiating adult-derived evidence from pediatric-specific outcomes. The methodology included examination of regulatory filings, professional society guidelines, and clinical pathway documentation to build a robust picture of best practices and emerging trends. Limitations of the research were explicitly noted, including variability in protocol reporting across institutions and the evolving evidence base for newer AI-driven tools; these limitations were addressed through sensitivity analyses and targeted follow-up interviews to validate key findings.

Synthesis of the key implications of technological adoption policy shifts and operational choices that will determine pediatric imaging success going forward

Pediatric imaging is at a pivotal juncture where technological progress offers tangible improvements in diagnostic accuracy, safety, and workflow efficiency, yet implementation requires careful alignment of clinical objectives, procurement strategy, and workforce capability. The combination of advanced imaging modalities, AI-assisted tools, and enhanced clinical protocols is reducing barriers to early and precise diagnoses across pediatric specialties, but success depends on thoughtful integration that prioritizes pediatric ergonomics, radiation stewardship, and ongoing clinician education.

Looking ahead, organizations that adopt flexible investment models, strengthen cross-institutional collaboration, and embed pediatric-specific quality metrics into operational governance will be better positioned to realize clinical and operational gains. As stakeholders respond to external pressures such as tariff volatility and supply chain realignment, the imperative is to focus on resilient architectures and partnerships that protect clinical continuity and preserve the capacity to innovate in support of child health.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Pediatric Imaging Market, by Modality

  • 8.1. Computed Tomography
  • 8.2. Magnetic Resonance Imaging
  • 8.3. Nuclear Imaging
    • 8.3.1. Positron Emission Tomography
    • 8.3.2. Single Photon Emission Computed Tomography
  • 8.4. Ultrasound
  • 8.5. X-Ray

9. Pediatric Imaging Market, by Age Group

  • 9.1. Adolescent
  • 9.2. Child
  • 9.3. Infant
  • 9.4. Newborn

10. Pediatric Imaging Market, by Technology

  • 10.1. Computed Radiography
  • 10.2. Digital Radiography
  • 10.3. Film-Screen Radiography

11. Pediatric Imaging Market, by End User

  • 11.1. Clinics And Ambulatory Surgical Centers
  • 11.2. Diagnostic Centers
  • 11.3. Hospitals
  • 11.4. Research Institutes

12. Pediatric Imaging Market, by Application

  • 12.1. Cardiology
  • 12.2. General Imaging
  • 12.3. Neurology
  • 12.4. Oncology
  • 12.5. Orthopedics

13. Pediatric Imaging Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Pediatric Imaging Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Pediatric Imaging Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Pediatric Imaging Market

17. China Pediatric Imaging Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Agfa-Gevaert Group
  • 18.6. Analogic Corporation
  • 18.7. Aspect Imaging Ltd
  • 18.8. BK Medical UK Ltd.
  • 18.9. Canon Inc.
  • 18.10. Carestream Health Inc.
  • 18.11. Esaote SpA
  • 18.12. FUJIFILM Holdings Corporation
  • 18.13. GE HealthCare Technologies Inc.
  • 18.14. Hitachi Ltd.
  • 18.15. Hologic Inc.
  • 18.16. Hyperfine
  • 18.17. Konica Minolta Inc.
  • 18.18. Koninklijke Philips N.V.
  • 18.19. LMT Medical Systems GmbH
  • 18.20. Mindray Medical International Limited
  • 18.21. Neoscan Solutions GmbH
  • 18.22. NORAS MRI products GmbH
  • 18.23. Samsung Electronics Co., Ltd.
  • 18.24. Shanghai United Imaging Healthcare Co., Ltd.
  • 18.25. Shenzhen Anke High-tech Co. Ltd
  • 18.26. Shenzhen SONTU Medical Imaging Equipment Co., Ltd.
  • 18.27. Shimadzu Corporation
  • 18.28. Siemens Healthcare GmbH
  • 18.29. Time Medical Holding

LIST OF FIGURES

  • FIGURE 1. GLOBAL PEDIATRIC IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PEDIATRIC IMAGING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PEDIATRIC IMAGING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES PEDIATRIC IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA PEDIATRIC IMAGING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PEDIATRIC IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY NUCLEAR IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY NUCLEAR IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY NUCLEAR IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY X-RAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY X-RAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY X-RAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY ADOLESCENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY ADOLESCENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY ADOLESCENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY CHILD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY CHILD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY CHILD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY INFANT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY INFANT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY INFANT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY NEWBORN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY NEWBORN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY NEWBORN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY COMPUTED RADIOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY COMPUTED RADIOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY COMPUTED RADIOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY DIGITAL RADIOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY DIGITAL RADIOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY DIGITAL RADIOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY FILM-SCREEN RADIOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY FILM-SCREEN RADIOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY FILM-SCREEN RADIOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY CLINICS AND AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY CLINICS AND AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY CLINICS AND AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY GENERAL IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY GENERAL IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY GENERAL IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY ORTHOPEDICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY ORTHOPEDICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS PEDIATRIC IMAGING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS PEDIATRIC IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS PEDIATRIC IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS PEDIATRIC IMAGING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS PEDIATRIC IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS PEDIATRIC IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS PEDIATRIC IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA PEDIATRIC IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA PEDIATRIC IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA PEDIATRIC IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA PEDIATRIC IMAGING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA PEDIATRIC IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA PEDIATRIC IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA PEDIATRIC IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA PEDIATRIC IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA PEDIATRIC IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA PEDIATRIC IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA PEDIATRIC IMAGING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA PEDIATRIC IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA PEDIATRIC IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA PEDIATRIC IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC IMAGING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC IMAGING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE PEDIATRIC IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE PEDIATRIC IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE PEDIATRIC IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE PEDIATRIC IMAGING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE PEDIATRIC IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE PEDIATRIC IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE PEDIATRIC IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST PEDIATRIC IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST PEDIATRIC IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST PEDIATRIC IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST PEDIATRIC IMAGING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST PEDIATRIC IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST PEDIATRIC IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST PEDIATRIC IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA PEDIATRIC IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA PEDIATRIC IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA PEDIATRIC IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA PEDIATRIC IMAGING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA PEDIATRIC IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA PEDIATRIC IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. AFRICA PEDIATRIC IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC PEDIATRIC IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC PEDIATRIC IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC PEDIATRIC IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC PEDIATRIC IMAGING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC PEDIATRIC IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC PEDIATRIC IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC PEDIATRIC IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN PEDIATRIC IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN PEDIATRIC IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 137. ASEAN PEDIATRIC IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN PEDIATRIC IMAGING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN PEDIATRIC IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 140. ASEAN PEDIATRIC IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN PEDIATRIC IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. GCC PEDIATRIC IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. GCC PEDIATRIC IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 144. GCC PEDIATRIC IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 145. GCC PEDIATRIC IMAGING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 146. GCC PEDIATRIC IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 147. GCC PEDIATRIC IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. GCC PEDIATRIC IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION PEDIATRIC IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPEAN UNION PEDIATRIC IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION PEDIATRIC IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION PEDIATRIC IMAGING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPEAN UNION PEDIATRIC IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION PEDIATRIC IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION PEDIATRIC IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. BRICS PEDIATRIC IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. BRICS PEDIATRIC IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 158. BRICS PEDIATRIC IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS PEDIATRIC IMAGING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 160. BRICS PEDIATRIC IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 161. BRICS PEDIATRIC IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS PEDIATRIC IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. G7 PEDIATRIC IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. G7 PEDIATRIC IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 165. G7 PEDIATRIC IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 166. G7 PEDIATRIC IMAGING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 167. G7 PEDIATRIC IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 168. G7 PEDIATRIC IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 169. G7 PEDIATRIC IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 170. NATO PEDIATRIC IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. NATO PEDIATRIC IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 172. NATO PEDIATRIC IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 173. NATO PEDIATRIC IMAGING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 174. NATO PEDIATRIC IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 175. NATO PEDIATRIC IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. NATO PEDIATRIC IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL PEDIATRIC IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED STATES PEDIATRIC IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 179. UNITED STATES PEDIATRIC IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 180. UNITED STATES PEDIATRIC IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 181. UNITED STATES PEDIATRIC IMAGING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 182. UNITED STATES PEDIATRIC IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 183. UNITED STATES PEDIATRIC IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 184. UNITED STATES PEDIATRIC IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. CHINA PEDIATRIC IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 186. CHINA PEDIATRIC IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 187. CHINA PEDIATRIC IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 188. CHINA PEDIATRIC IMAGING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 189. CHINA PEDIATRIC IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 190. CHINA PEDIATRIC IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. CHINA PEDIATRIC IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)